Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline Supplementation in Fetal Alcohol Spectrum Disorders
NCT05108974Phase 2Active, not recruiting
- Start
- Oct 2021
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of choline in Fetal Alcohol Spectrum Disorders (FASDs) (2 arms). Primary endpoints: Elicited Imitation Memory Task at 9 months, Stanford-Binet Intelligence Test at 9 months and 3 more. Started Oct 2021; status: active, not recruiting.
02
Drugs
choline
03
Conditions
Fetal Alcohol Spectrum Disorders (FASDs)
Beyond the preview
Go deeper on NCT05108974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05108974.